A History of Reproductive Health

by | May 14, 2021 | FDA, Healthcare, Quality, Regulatory, Women, Women's Health

Happy National Women’s Health Week! In honor of this week bringing light to important women’s health issues, I wanted to walk through a brief history of innovations that shaped one of the largest facets of women’s health – reproductive health.

The first-ever oral contraceptive was officially approved by the FDA in 1960. The drug, Enovid, was originally submitted for regulatory approval in 1957 as a treatment for infertility and menstrual disorders. Two years later, in 1959, Enovid was submitted for approval as an oral contraceptive.1 Thus, “The Pill” was born and kickstarted the regulatory landscape for women’s health. The regulatory submission for Enovid as an oral contraceptive included data from the largest drug trials ever run, including 897 women who had taken 10,427 cycles of the pill.2

The approval of “The Pill” jumpstarted an important scientific movement aimed at developing safe and effective contraceptives. In the ’80s, the Copper IUD, ParaGard, was approved by the FDA. Almost 2 decades later, in 2001, the first hormonal IUD was made available. Current data shows that IUDs are the second most popular form of contraception, behind the pill, with approximately 4.4 million users in the US.3 The modern IUD was a modern marvel with respect to women’s health. As a long-acting reversible contraceptive (LARC), it provided women effective control over their reproductive health with reduced risk for user error.

In 2018, the CDC estimated that nearly 70% of all women in the United States used some form of contraception.4 While contraceptives are easily accessible in the US, there is a shortage of available contraceptives to women in some developing countries, constituting a global reproductive health emergency. As technology continues to develop, and more focus is given to important women’s health issues, birth control as we know it continues to develop to be more safe, effective, and accessible.

All forms of contraception, from condoms to IUDs, fall within the jurisdiction of the FDA. As a proud women-owned business, EMMA International has helped bring safe and effective women’s health products to the market. If you are in need of quality and regulatory support, give us a call at 248-987-4497 or email info@emmainternational.com to learn more.

1Junod, S., Ph.D (1998) FDA’s Approval of the First Oral Contraceptive, Enovid retrieved on 05/11/2021 from: https://www.fda.gov/media/110456/download#:~:text=The%20first%20oral%20contraceptive%20was,developed%20as%20an%20oral%20contraceptive).

2PBS (n.d.) The FDA Approves the Pill retrieved on 05/11/2021 from: https://www.pbs.org/wgbh/americanexperience/features/pill-us-food-and-drug-administration-approves-pill/

3Kavanaugh, M., & Hubacher, D. (2018) Historical record-setting trends in IUD use in the United States retrieved on 05/11/2021 from: https://www.contraceptionjournal.org/article/S0010-7824(18)30192-6/pdf#:~:text=US%20data%20from%20the%20National,imately%204.4%20million%20%5B4%5D.

4CDC (2018) Current Contraceptive Status Among Women retrieved on 05/13/2021 from: https://www.cdc.gov/nchs/products/databriefs/db327.htm#:~:text=In%202015%E2%80%932017%2C%2064.9%25,and%20male%20condom%20(8.7%25).

Madison Green

Madison Green

Director of Technical Operations - Mrs. Green serves as EMMA International’s Director of Technical Operations. She has experience in technical writing, nonconforming product management, issue evaluations, and implementing corrective and preventative actions in the pharmaceuticals and medical device industries. She has experience cross-functionally between R&D, lean manufacturing operations, and RA compliance. Mrs. Green also has academic and work experience with human health-risk engineering controls, physiological biophysics, and clinical research. Mrs. Green holds a Bachelor of Science in Biosystems Engineering with a concentration in Biomedical Engineering from Michigan State University. She is also a Certified Quality Auditor (CQA), and is currently pursuing her M.S. in Quality Management.

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This